<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-397
Date of Submission: 2025-01-04

This report was submitted by a Nurse from Morton-Cole Medical Center concerning patient ANON-PX-6855. The subject is a 60-year-old female with a significant medical history including coronary artery disease, anxiety, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Warfarin administered via the Subcutaneous route at a dosage of 268mg, initiated on 2024-12-04 for Thromboembolism prevention with the course ongoing.

On approximately 2024-12-29, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Vomiting, Somnolence. The Dizziness was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed play and advised look. The current patient status regarding this symptom is 'Recovering'. The Vomiting was classified as Mild in severity. This necessitated clinical intervention. The documented action was: Prescribed training and advised war. The current patient status regarding this symptom is 'Unknown'. The Somnolence was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 8 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Free be chair exactly. Understand reason lay plant hair.</data>
report_id: ADR-2025-397
report_date: '2025-01-04'
patient_details:
  patient_id: ANON-PX-6855
  gender: Female
  relevant_history:
  - coronary artery disease
  - anxiety
  - seasonal allergies
  age_at_reaction: 60
suspected_drugs:
- drug_name: Warfarin
  dosage: 268mg
  route_of_administration: Subcutaneous
  start_date: '2024-12-04'
  indication_for_use: Thromboembolism prevention
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-12-29'
  severity: Mild
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed play and advised look.
- symptom_name: Vomiting
  onset_date: '2024-12-29'
  severity: Mild
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed training and advised war.
- symptom_name: Somnolence
  onset_date: '2024-12-29'
  severity: Mild
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
  naranjo_score: 8
reporting_facility: Morton-Cole Medical Center
reporter_type: Nurse
notes: Free be chair exactly. Understand reason lay plant hair.
